{"entity":{"type":"insider","cik":"0001270734","url":"/insider/0001270734","json_url":"/insider/0001270734.json","name":"PAKIANATHAN DEEPIKA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":18,"first":"2006-03-09","last":"2024-08-23","span_basis":"filed_date"},"name_variants":[{"name":"PAKIANATHAN DEEPIKA","source":"filing","n_filings":18,"first_seen":"2006-03-09","last_seen":"2024-08-23"}],"transactions":[{"id":2851720,"accession":"0000950170-24-100281","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-100281","line_url":"/filing/0000950170-24-100281#line-7","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Mereo BioPharma Group plc","issuer_ticker":"MREO","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105244.0,"shares_display":"105,244","price_per_share":4.4298,"price_display":"4.43","price_state":"stated","total_value":466209.8712,"total_display":"466,209.87","total_whole":"466,210","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-23","scope":"insider"},{"id":2850920,"accession":"0000950170-24-070991","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-070991","line_url":"/filing/0000950170-24-070991","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231548.0,"shares_display":"231,548","price_per_share":0.9507,"price_display":"0.95","price_state":"stated","total_value":220132.6836,"total_display":"220,132.68","total_whole":"220,133","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-07","scope":"insider","n_lines":2},{"id":2850914,"accession":"0000950170-24-070991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-070991","line_url":"/filing/0000950170-24-070991","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118452.0,"shares_display":"118,452","price_per_share":0.9828,"price_display":"0.98","price_state":"stated","total_value":116414.6256,"total_display":"116,414.63","total_whole":"116,415","shares_owned_after":229308.0,"shares_owned_after_display":"229,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-06","filed_date":"2024-06-07","scope":"insider","n_lines":2},{"id":2850907,"accession":"0000950170-24-070991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-070991","line_url":"/filing/0000950170-24-070991","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":468044.0,"shares_display":"468,044","price_per_share":0.9582,"price_display":"0.96","price_state":"stated","total_value":448479.7608,"total_display":"448,479.76","total_whole":"448,480","shares_owned_after":346615.0,"shares_owned_after_display":"346,615","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider","n_lines":2},{"id":2544622,"accession":"0000950170-24-068969","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-068969","line_url":"/filing/0000950170-24-068969","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":341040.0,"shares_display":"341,040","price_per_share":0.9521,"price_display":"0.95","price_state":"stated","total_value":324704.184,"total_display":"324,704.18","total_whole":"324,704","shares_owned_after":810133.0,"shares_owned_after_display":"810,133","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-04","scope":"insider","n_lines":2},{"id":2544615,"accession":"0000950170-24-068969","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-068969","line_url":"/filing/0000950170-24-068969","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360744.0,"shares_display":"360,744","price_per_share":1.0007,"price_display":"1.00","price_state":"stated","total_value":360996.5208,"total_display":"360,996.52","total_whole":"360,997","shares_owned_after":1147875.0,"shares_owned_after_display":"1,147,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider","n_lines":2},{"id":2544602,"accession":"0000950170-24-068969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-068969","line_url":"/filing/0000950170-24-068969","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204394.0,"shares_display":"204,394","price_per_share":0.954,"price_display":"0.95","price_state":"stated","total_value":194991.876,"total_display":"194,991.88","total_whole":"194,992","shares_owned_after":1505131.0,"shares_owned_after_display":"1,505,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-04","scope":"insider","n_lines":2},{"id":8350624,"accession":"0000899243-23-003071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003071","line_url":"/filing/0000899243-23-003071","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121333.0,"shares_display":"121,333","price_per_share":0.3858,"price_display":"0.39","price_state":"stated","total_value":46810.2714,"total_display":"46,810.27","total_whole":"46,810","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider","n_lines":2},{"id":6364773,"accession":"0000899243-22-021957","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-021957","line_url":"/filing/0000899243-22-021957","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1307.0,"shares_display":"1,307","price_per_share":6.0019,"price_display":"6.00","price_state":"stated","total_value":7844.4833,"total_display":"7,844.48","total_whole":"7,844","shares_owned_after":1707549.0,"shares_owned_after_display":"1,707,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-10","filed_date":"2022-06-10","scope":"insider","n_lines":2},{"id":6364771,"accession":"0000899243-22-021957","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-021957","line_url":"/filing/0000899243-22-021957","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211500.0,"shares_display":"211,500","price_per_share":6.1798,"price_display":"6.18","price_state":"stated","total_value":1307027.7,"total_display":"1,307,027.70","total_whole":"1,307,028","shares_owned_after":1708843.0,"shares_owned_after_display":"1,708,843","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-10","scope":"insider","n_lines":2},{"id":6364769,"accession":"0000899243-22-021957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021957","line_url":"/filing/0000899243-22-021957","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325977.0,"shares_display":"325,977","price_per_share":6.5033,"price_display":"6.50","price_state":"stated","total_value":2119926.2241,"total_display":"2,119,926.22","total_whole":"2,119,926","shares_owned_after":1918298.0,"shares_owned_after_display":"1,918,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider","n_lines":2},{"id":3208873,"accession":"0001209191-16-110187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-110187","line_url":"/filing/0001209191-16-110187","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"Senseonics Holdings, Inc.","issuer_ticker":"SENS","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"PAKIANATHAN DEEPIKA; DOUGLASS DAVID L; Delphi Management Partners VIII, L.L.C.; BOCHNOWSKI JAMES J; Delphi BioInvestments VIII LP; ROEDER DOUGLAS A; DELPHI VENTURES VIII LP","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1228070.0,"shares_display":"1,228,070","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":3499999.5,"total_display":"3,499,999.50","total_whole":"3,500,000","shares_owned_after":11237221.0,"shares_owned_after_display":"11,237,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-23","filed_date":"2016-03-23","scope":"insider","n_lines":2},{"id":8406932,"accession":"0001209191-15-004180","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-004180","line_url":"/filing/0001209191-15-004180","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45454.0,"shares_display":"45,454","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":1499982.0,"total_display":"1,499,982.00","total_whole":"1,499,982","shares_owned_after":2241123.0,"shares_owned_after_display":"2,241,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-14","scope":"insider","n_lines":2},{"id":7035270,"accession":"0001209191-14-062661","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-062661","line_url":"/filing/0001209191-14-062661","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2403238.0,"shares_owned_after_display":"2,403,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":6205582,"accession":"0001209191-14-062753","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-062753","line_url":"/filing/0001209191-14-062753","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP; PAKIANATHAN DEEPIKA; ROEDER DOUGLAS A; BOCHNOWSKI JAMES J; Delphi BioInvestments VIII LP; DOUGLASS DAVID L","owner_display_name":"Delphi Management Partners VIII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2403238.0,"shares_owned_after_display":"2,403,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":6753150,"accession":"0001181431-14-029918","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-029918","line_url":"/filing/0001181431-14-029918","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21603.0,"shares_display":"21,603","price_per_share":18.9782,"price_display":"18.98","price_state":"stated","total_value":409986.0546,"total_display":"409,986.05","total_whole":"409,986","shares_owned_after":1991602.0,"shares_owned_after_display":"1,991,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-21","filed_date":"2014-08-21","scope":"insider","n_lines":2},{"id":6753145,"accession":"0001181431-14-029918","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-029918","line_url":"/filing/0001181431-14-029918","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46059.0,"shares_display":"46,059","price_per_share":18.9973,"price_display":"19.00","price_state":"stated","total_value":874996.6407,"total_display":"874,996.64","total_whole":"874,997","shares_owned_after":1970200.0,"shares_owned_after_display":"1,970,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider","n_lines":2},{"id":6753138,"accession":"0001181431-14-029918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-029918","line_url":"/filing/0001181431-14-029918","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12541.0,"shares_display":"12,541","price_per_share":18.8892,"price_display":"18.89","price_state":"stated","total_value":236889.4572,"total_display":"236,889.46","total_whole":"236,889","shares_owned_after":1924570.0,"shares_owned_after_display":"1,924,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-19","filed_date":"2014-08-21","scope":"insider","n_lines":2},{"id":6720873,"accession":"0001179110-14-009095","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-009095","line_url":"/filing/0001179110-14-009095","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1769.0,"shares_display":"1,769","price_per_share":26.4466,"price_display":"26.45","price_state":"stated","total_value":46784.0354,"total_display":"46,784.04","total_whole":"46,784","shares_owned_after":2196109.0,"shares_owned_after_display":"2,196,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-23","filed_date":"2014-05-23","scope":"insider","n_lines":2},{"id":6720867,"accession":"0001179110-14-009095","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-009095","line_url":"/filing/0001179110-14-009095","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":26.0902,"price_display":"26.09","price_state":"stated","total_value":521804.0,"total_display":"521,804.00","total_whole":"521,804","shares_owned_after":2194357.0,"shares_owned_after_display":"2,194,357","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-23","scope":"insider","n_lines":2},{"id":6720863,"accession":"0001179110-14-009095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-009095","line_url":"/filing/0001179110-14-009095","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":92650.0,"shares_display":"92,650","price_per_share":26.194,"price_display":"26.19","price_state":"stated","total_value":2426874.1,"total_display":"2,426,874.10","total_whole":"2,426,874","shares_owned_after":2174550.0,"shares_owned_after_display":"2,174,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-21","filed_date":"2014-05-23","scope":"insider","n_lines":2},{"id":6875113,"accession":"0001209191-14-034322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-034322","line_url":"/filing/0001209191-14-034322","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"PAKIANATHAN DEEPIKA; Delphi Management Partners VII, L.L.C.; BOCHNOWSKI JAMES J; DOUGLASS DAVID L; DELPHI BIOINVESTMENTS VII LP; ROEDER DOUGLAS A; DELPHI VENTURES VII L P","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","total_whole":"3,500,000","shares_owned_after":2835067.0,"shares_owned_after_display":"2,835,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-15","scope":"insider","n_lines":2},{"id":6797400,"accession":"0001209191-14-034320","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-034320","line_url":"/filing/0001209191-14-034320","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","total_whole":"3,500,000","shares_owned_after":2835067.0,"shares_owned_after_display":"2,835,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-15","scope":"insider","n_lines":2},{"id":6717430,"accession":"0000906344-14-000024","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000906344-14-000024","line_url":"/filing/0000906344-14-000024#line-6","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"TriVascular Technologies, Inc.","issuer_ticker":"TRIV","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"DOUGLASS DAVID L; Delphi Management Partners VIII, L.L.C.; PAKIANATHAN DEEPIKA; ROEDER DOUGLAS A; DELPHI BIOINVESTMENTS VII LP; Delphi BioInvestments VIII LP; Delphi Management Partners VII, L.L.C.; DELPHI VENTURES VIII LP; BOCHNOWSKI JAMES J; DELPHI VENTURES VII L P","owner_display_name":"DOUGLASS DAVID L","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":833333.0,"shares_display":"833,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":9999996.0,"total_display":"9,999,996.00","total_whole":"9,999,996","shares_owned_after":833333.0,"shares_owned_after_display":"833,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-22","filed_date":"2014-04-24","scope":"insider"},{"id":4857227,"accession":"0001104659-13-084849","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-084849","line_url":"/filing/0001104659-13-084849","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2082796.0,"shares_owned_after_display":"2,082,796","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-12","filed_date":"2013-11-14","scope":"insider","n_lines":2},{"id":5359083,"accession":"0001181431-13-041153","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-041153","line_url":"/filing/0001181431-13-041153","is_derivative":false,"issuer_cik":"0001270734","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001270734","owner_cik":"0001270734","owner_name":"PAKIANATHAN DEEPIKA","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":"/insider/0001270734","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":382353.0,"shares_display":"382,353","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":6500001.0,"total_display":"6,500,001.00","total_whole":"6,500,001","shares_owned_after":1912145.0,"shares_owned_after_display":"1,912,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2013-07-23|5359080","ledger_fault":false,"count":{"value":44,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":23,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":44},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001719714","name":"Mereo BioPharma Group plc","url":"/issuer/0001719714","role":"Director","n_filings":1,"first_seen":"2024-08-23","last_seen":"2024-08-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Director","n_filings":6,"first_seen":"2013-11-14","last_seen":"2024-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001496671","name":"Calithera Biosciences, Inc.","url":"/issuer/0001496671","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2014-10-09","last_seen":"2023-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001616543","name":"Senseonics Holdings, Inc.","url":"/issuer/0001616543","role":"Ten percent owner","n_filings":1,"first_seen":"2016-03-23","last_seen":"2016-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Director","n_filings":2,"first_seen":"2013-07-23","last_seen":"2014-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001423824","name":"ALDER BIOPHARMACEUTICALS INC","url":"/issuer/0001423824","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2014-05-15","last_seen":"2014-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001432732","name":"TriVascular Technologies, Inc.","url":"/issuer/0001432732","role":"Ten percent owner","n_filings":1,"first_seen":"2014-04-24","last_seen":"2014-04-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001230355","name":"TRANS1 INC","url":"/issuer/0001230355","role":"Ten percent owner","n_filings":1,"first_seen":"2009-03-03","last_seen":"2009-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001344413","name":"Alexza Pharmaceuticals Inc.","url":"/issuer/0001344413","role":"Director","n_filings":1,"first_seen":"2006-03-09","last_seen":"2006-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001270734","retrieved_at":"2026-08-23T05:02:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}